Patents by Inventor Eric URENO

Eric URENO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS CONTAINING ACTIVATABLE ANTIBODIES
    Publication number: 20250382351
    Abstract: The invention provides a composition including an intact activatable antibody and a clipped variant thereof, methods of separating clipped variants of intact activatable antibodies from intact activatable antibodies and related methods including methods for determining or monitoring a relative percentage of an activatable antibody and a clipped variant thereof during a composition production process.
    Type: Application
    Filed: September 2, 2025
    Publication date: December 18, 2025
    Applicant: CYTOMX THERAPEUTICS, INC.
    Inventors: Sarah PATRICK, Claus KREBBER, Sridhar VISWANATHAN, Shanti Gonela DUVUR, Eric URENO
  • Compositions containing activatable antibodies
    Patent number: 12428470
    Abstract: The invention provides a composition including an intact activatable antibody and a clipped variant thereof, methods of separating clipped variants of intact activatable antibodies from intact activatable antibodies and related methods including methods for determining or monitoring a relative percentage of an activatable antibody and a clipped variant thereof during a composition production process.
    Type: Grant
    Filed: April 9, 2021
    Date of Patent: September 30, 2025
    Assignee: CytomX Therapeutics, Inc.
    Inventors: Sarah Patrick, Claus Krebber, Sridhar Viswanathan, Shanti Gonela Duvur, Eric Ureno
  • COMPOSITIONS CONTAINING ACTIVATABLE ANTIBODIES
    Publication number: 20210317188
    Abstract: The invention provides a composition including an intact activatable antibody and a clipped variant thereof, methods of separating clipped variants of intact activatable antibodies from intact activatable antibodies and related methods including methods for determining or monitoring a relative percentage of an activatable antibody and a clipped variant thereof during a composition production process.
    Type: Application
    Filed: April 9, 2021
    Publication date: October 14, 2021
    Applicant: CytomX Therapeutics, Inc.
    Inventors: Sarah PATRICK, Claus KREBBER, Sridhar VISWANATHAN, Shanti Gonela DUVUR, Eric URENO